Using Evidence to Advance Your Practice (2nd Edition)

Activity Preview

This program will guide pharmacists in handling uncertainty when making drug-related recommendations by considering the findings from current literature evidence. The program focuses on learning the principles and approaches used in evidence-based practice to assess patients’ medication needs, formulate and document patient care plans and collaborate with other members of the health care team.

Modules & Learning Objectives

Module 1: Introduction: Overview of Study Design

  •   Define the various types of observational and experimental studies.
  •   Describe the key featrues of each study design.
  •   Explain the different methods of analyzing data.

Module 2: An Overview of Randomized Control Study Design

  •   Explain the purpose of inclusion and exclusion criteria.
  •   Discuss the various types of error in randomized controlled trials.
  •   Describe the different types of outcome analysis in randomized control trials.
  •   Identify appropriate statistical analysis based on type of variable presented.
  •   Apply the principles of data analysis to formulate a clinical recommendation for a patient.

Module 3: An Overview of Meta-Analysis Design

  •   Define systematic reviews and meta-analysis.
  •   Describe the elements to consider in appraising a meta-analysis.
  •   Discuss the steps involved in searching for studies for meta-anaysis inclusion.
  •   Explain how to interpret the systematic review findings of a meta-analysis.
  •   Apply the principles of data analysis to formulate a clinical recommendation for a patient.

Module 4: An Overview of Observational Study Design

  •   Describe the elements analyzed in the appraisal of an observational study.
  •   Describe how to calculate the various measures of risk in observational studies.
  •   Explain how to interpret the measures of association in observational studies.
  •   Discuss how to determine the strength of correlation in observational studies.
  •   Apply the principles of data analysis to formulate a clinical recommendation for a patient.

Module 5: An Overview on How to Appraise Practice Guidelines

  •   Discuss the advantages and disadvantages of clinical practice guidelines.
  •   Identify the factors that impact the quality of evidence.
  •   Describe how different organizations grade various sources of evidence.
  •   Explain the challenges of applying recommendations from clinical practice guidelines.
  •   Apply the principles of data analysis to formulate a clinical recommendation for a patient.

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Using Evidence to Advance Your Practice is approved for 15.5 contact hours (1.55 CEUs) of continuing pharmacy education credit.

To earn continuing pharmacy education (CPE) credit for this advanced training program, participants must achieve a passing grade of 70% or higher on each module assessment and complete module evaluations. To obtain credit, the learner must CLAIM credit once each module is completed. After credit has been claimed, please visit CPE Monitor for your transcript. Learners will be able to immediately print a Certificate of Completion will be upon successful completion of the program requirements.

APhA's continuing pharmacy education policy provides you with two opportunities to successfully complete each assessment. Please note that you will not be permitted to submit an assessment a third time. All assessment questions are randomized. The current policy of the APhA Education Department is to not release the correct answers to any of our CPE assessments. This policy is intended to maintain the integrity of the CPE activity and the assessment.

ACPE UANs

Module 1: Introduction: Overview of Study Design is approved for 1.5 hours (0.15 CEUs) of continuing pharmacy education credit (UAN 0202-0000-18-140-H04-P).

Release Date: March 15, 2018

Expiration Date: March 15, 2021

Activity Type: Knowledge-based

Target Audience: Pharmacists in all practice settings

 

Module 2: An Overview of Randomized Control Study Designis approved for 3.5 hours (0.35 CEUs) of continuing pharmacy education credit (UAN 0202-0000-18-141-H04-P).

Module 3: An Overview of Meta-Analysis Design is approved for 3.5 hours (0.35 CEUs) of continuing pharmacy education credit (UAN 0202-0000-18-142-H04-P).

Module 4: An Overview of Observational Study Design is approved for 3.5 hours (0.35 CEUs) of continuing pharmacy education credit (UAN 0202-0000-18-143-H04-P).

Module 5: An Overview on How to Appraise Practice Guidelines is approved for 3.5 hours (0.35 CEUs) of continuing pharmacy education credit (UAN 0202-0000-18-144-H04-P).

Release Date: March 15, 2018

Expiration Date: March 15, 2021 

Activity Type: Application-based

Target Audience: Pharmacists in all practice settings

 

Acknowledgements

Timothy D. Gladwell, PharmD, BCPS, BCACP

Associate Dean for Academic Affairs and Assessment

University of Maryland Eastern Shore

School of Pharmacy and Health Professions

Princess Anne, MD

 

Stuart T. Haines, PharmD, BCPS, BCACP, BC-ADM

Professor and Director, Division of Pharmacy Professional Development

Department of Pharmacy Practice

University of Mississippi School of Pharmacy

Jackson, MS

 

Suzanne Higginbotham, B.S., PharmD, BCACP

Director of Center for Pharmacy Care and Duquesne University Pharmacy

Director of Residency Programs

Duquesne University Mylan School of Pharmacy

Pittsburgh, PA

 

Sharon K. Park, PharmD, BCPS

Associate Professor, Clinical and Administrative Sciences

Notre Dame of Maryland University School of Pharmacy

Baltimore, MD

 

Development

Using Evidence to Advance Your Practice is a home study activity for pharmacists developed by the American Pharmacists Association.                                                                                   

Disclosures

All individuals involved in the development of this material declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria.

APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, please visit the APhA website at www.pharmacist.com/apha-disclosures.  Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association. 

Fee

The fee for this activity is $125 for APhA members and $275 for non-members. 

System Requirements

Computer and Internet access is required to complete this activity.  Please visit our website to view the Technology System Requirements for a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-18-140-H04-P 0.15 CEUs March 15, 2018 - March 15, 2021
ACPE# 0202-0000-18-141-H04-P 0.35 CEUs March 15, 2018 - March 15, 2021
ACPE# 0202-0000-18-142-H04-P 0.35 CEUs March 15, 2018 - March 15, 2021
ACPE# 0202-0000-18-143-H04-P 0.35 CEUs March 15, 2018 - March 15, 2021
ACPE# 0202-0000-18-144-H04-P 0.35 CEUs March 15, 2018 - March 15, 2021
EBM 0.001 Hours from March 15, 2018